There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

Q1 2025 Management View Shantanu Gaur, CEO, stated the company "delivered the first quarter in line with expectations, ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a ...

Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool ...